When the mid-afternoon rolls around, many of us wouldn’t mind curling up in bed and taking a nap. In fact, a recent study conducted by GfK’s KnowledgePanel® found that one-third of Americans say they feel drowsy, less productive and worn out several times a week, at an average of 2:58 pm.
This afternoon crash can be improved with the help of a healthy snack like almonds. Together, California Almonds and actress Anna Camp have partnered to ensure Americans can “Carpe PM” – or “seize the afternoon” -- and crunch their crash.
To view the multimedia release go to:
https://www.multivu.com/players/English/8118051-california-almonds-anna-camp-carpe-pm/
Today, the award-winning Adoption from Foster Care campaign from the U.S. Department of Health and Human Services, AdoptUSKids and the Ad Council unveiled a new series of public service advertisements (PSAs) that aim to encourage the adoption of older youth from foster care.
Of the 415,000 children in the U.S. foster care system, 108,000 children under the age of 18 are currently waiting for adoptive families, according to the Adoption and Foster Care Analysis and Reporting System (AFCARS). Since the AdoptUSKids project began in 2002, 25,000 children who were once photo listed on adoptuskids.org are now with their adoptive families and nearly 38,000 families have registered to adopt through AdoptUSKids. 41 percent of the approximately 5,360 youth listed on the website are aged between 15 and 18 years old.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7673451-ad-council-national-adoption-campaign/
The American Association for Cancer Research (AACR) today released its annual Cancer Progress Report highlighting how federally funded research discoveries are fueling the development of new and even more effective ways to prevent, detect, diagnose, and treat cancer.
To view the multimedia release go to:
https://www.multivu.com/players/English/8385551-aacr-cancer-progress-report-2018/
Announced today by VICHY Laboratoires, the VICHY EXPOSOME GRANT will promote and encourage research activity on the skin exposome. One research grant of 15 000 € will be awarded annually to a research project proposal in the field of exposome and skin.
What is exposome?
The human body is subjected to and responds to complex exposures throughout the lifespan, including exposures from the environment, diet, lifestyle. For this highly complex interaction, the term exposome was recently coined by Dr. Christopher Wild at the World Health Organization‘s International Agency for Research on Cancer.
The exposome analysis, therefore, complements the human genome by providing a comprehensive description of individuals’ lifelong environmental exposures. Exposome research aims to look at the holistic view of the human body’s exposures, how the body responds to those exposures, and their combined effects.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7751451-vichy-announces-exposome-grant/
Do You Want Your Love Life Back?
Have you lost your love making ability? Has your hardness changed and has caused you some embarrassment? You don’t have to suffer the shame or fear that comes with lack of hardness when your love partner is ready for you. Are you starting for feel like less of a man?
Have you dreamed of a skincare product promising youth-preserving results only to be let down time and time again? Now you can make that dream a reality, as USANA launches its high-performance skincare system, Celavive®. This unique line is fueled by USANA InCelligence Technology®, a combination of powerful peptides, botanicals and key nutrients that talk to your skin’s cells to target your unique beauty needs.
As we age, our cellular function slows and becomes less effective, resulting in wrinkles and loss of firmness. By tapping into USANA InCelligence Technology, Celavive is able to signal your beauty-preserving functions to support your natural ability to retain moisture from within. It also supports other key elements that help contribute to a younger-looking complexion.
To view the multimedia release go to:
https://www.multivu.com/players/English/7736552-usana-celavive-skincare-line/
Installation of an array of 18 230Watt Solar Panels, wired in 6 series or "strings" of 3 panels each. These panels were mounted to roof with a UniSolar Rail Mounting System. We have used "weebs" to ground the panels to the rail and ran a grounding wire to connect the rails.
System specs and major component parts:
48Volt Nominal System
4100Watt Solar Array (18 x 230Watt SoPray Polycrystalline Photovoltaic Solar Panels)
4400Watt 48V Magnum Pure-Sine Inverter,
Outback FM80 80Amp Charge Controller with MPPT
16 x L-16 6V Deep Cycle Batteries
Main Enclosure Panel (Custom API E-Panel)
MidNite Solar 6 String Combiner Box
UniSolar Roof Rack and Fast Jack Mounting
**Solar power arrays and components are designed to be installed by professionals. They are Dangerous electrical instruments. Misuse could result in injury or death. Please do not try this at home.
Next week at the Consumer Electronics Showcase (CES) in Las Vegas, Neutrogena® will debut sophisticated skin imaging technology that allows consumers to measure what’s happening above and below their skin’s surface. The Neutrogena Skin360™ app and the accompanying SkinScanner powered by FitSkin™ give users an in depth understanding of their skin’s condition and needs, customized advice to address those needs, plus a clear way to track and assess skin’s progress over time.
“Shopping for skincare products can be an overwhelming and confusing experience for our consumer because she is uncertain about what her skin really needs,” said Sebastien Guillon, Global President of Beauty, Johnson & Johnson Consumer. “Smart and connected technology helps us provide our consumer with personalized analyses and information she needs in real time so she can make decisions that will help her achieve her best skin ever.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8250251-neutrogena-skin360-skinscanner-fitskin-ces/
Heart disease affects all of us, either directly or indirectly. It is the leading cause of death in the United States. In an effort to make a positive difference in women's heart health, Progresso Heart Healthy soup is launching
Today, the Ad Council in partnership with the U.S. Department of Health and Human Services, AdoptUSKids, and KBS launched new public service advertisements (PSAs) for the award-winning Adoption from Foster Care campaign. The new television and radio PSAs encourage the adoption of older youth from foster care.
Of the 428,000 youth under the age of 18 in the U.S. foster care system, 112,000 are currently waiting for adoptive families, according to the most recent Adoption and Foster Care Analysis and Reporting System (AFCARS) data. Since the project’s launch in 2002, more than 26,000 children who were once photo listed on the AdoptUSKids website have been placed with permanent families. However, older youth and teens have lower adoption rates than younger children, and they often wait longer to be adopted. Currently, of the 5,560 youth photo-listed on the website as available for adoption, 43% are between the ages of 15 and 18 years old.
To view the multimedia release go to:
http://www.multivu.com/players/English/7979251-ad-council-adoptuskids-adopt-from-foster-care/
Be a champion for wellness by liking United Concordia’s Facebook page and casting your vote Oct. 1 – Nov. 30 for one of three national charities – American Diabetes Association, March of Dimes or Arthritis Foundation.
Through the “Champions for Wellness” charity program, visitors who “like” United Concordia’s Facebook page can award a total of $25,000 to charity while learning about the connection between oral and overall wellness.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58162-united-concordia-champions-for-wellness-charity-program
Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers.
“The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/
